Poolbeg Pharma (Poolbeg Pharma PLC (AIM:POLB)) Jeremy Skillington joins Proactive London to talk about their full licence to develop oral vaccine delivery platform agreed.
The firm has signed a licence agreement with AnaBio Technologies, a specialist micro encapsulation company, to exclusively develop an oral vaccine delivery platform.
He says vaccine uptake is a critical factor in the effectiveness of combating communicable infectious diseases, something that the COVID-19 pandemic has shown in recent months.